About NLC
NLC is a venture capital firm founded in 2014. It is primarily based out of Amsterdam, Netherlands. As of Sep 2025, NLC is an active investor, having invested in 49 companies, with 2 new investments in the last 12 months. It primarily invests in Series A round in Netherlands based startups. Its investments are spread across a wide range of sectors from Life Sciences to HealthTech and Enterprise Applications. Most recently it participated in the $***** Seed round of Ansana A lot of funds co-invest with NLC, with names like Demcon sharing a substantial percentage of its portfolio. NLC has team of 54 people including 11 partners.Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Seed & Series A
NLC's List of Top Investments
NLC has a portfolio of 49 companies. Their most notable investments are in Scinvivo and SERDA Therapeutics.Their portfolio spans across Netherlands, United Kingdom, Austria and 3 more locations. They have invested in Life Sciences, HealthTech, Enterprise Applications and 2 other sectors, across stages such as Seed, Series A stages. Here is the list of top investments by NLC:
1. Pephealth AI
Provider of an AI based patient feedback management software for healthcare providers. The platform uses algorithms to gather and combine publicly available feedbacks of patients regarding the provider's care. The system also generates a score based on the feedback collected from social media.
Key facts about Pephealth AI
- Founded Year: 2020
- Location: London (United Kingdom)
- Stage: Funding Raised
- Employee Count: 19 as on Dec 31, 2024
- Investors: NLC
- Highlight: Editors' Pick
2. IPD
Provider of treatment for prosthetic joint & metal implant infections. The company has developed an induction technology, the implant is heated while still inside the patient- eliminating bacteria on the implant and ultimately curing the infection.
Key facts about IPD
- Founded Year: 2020
- Location: Leiden (Netherlands)
- Stage: Seed
- Total Funding till date: $1.7M
- Employee Count: 2 as on Jul 01, 2024
- Investors: InnovationQuarter, Libertatis Ergo Holding and 1 Other
- Latest Funding Round: Seed, 2021, $*****
_1536136725876.png?format=webp&height=120&width=120){kind=logo}
3. MindAffect
Manufacturer and developer of industrial robots. It supports communication and interaction for locked-in patients. The device is a headset that measures the electrical brain signals to control a computer for communicating using the brain-computer interface. The device doesn't need any training and can be controlled well with continuous use.
Key facts about MindAffect
- Founded Year: 2017
- Location: Nijmegen (Netherlands)
- Stage: Series A
- Total Funding till date: $2.37M
- Employee Count: 7 as on Jul 01, 2024
- Investors: Oost NL, ScaleUpNation and 5 Others
- Latest Funding Round: Series A, Apr 29, 2024, $*****
- Highlight: Editors' Pick
4. Amotio
Provider of personalized bone cement removal solutions for orthopaedic revision surgery. It specializes in addressing the challenges of orthopaedic revision surgery through patient-specific solutions. It offers digital joint templating, 3D-printed surgical guides, and precision cutting instruments that helps reduce surgery time, preserve bone, and enhance patient recovery.
Key facts about Amotio
- Founded Year: 2023
- Location: Cwmbran (United Kingdom)
- Stage: Seed
- Total Funding till date: $1.1M
- Employee Count: 3 as on Mar 31, 2025
- Investors: Development Bank of Wales, Orthopaedic Research and 1 Other
- Latest Funding Round: Seed, Jul 07, 2025, $*****
5. ProVascTec
Developer of cell therapy device to treat cardiovascular complications. The company leverages the paracrine mechanism of stem cells to develop cell-therapy delivery devices for intravascular placement upstream of blood vessels.
Key facts about ProVascTec
- Founded Year: 2021
- Location: Galway (Ireland)
- Stage: Funding Raised
- Investors: Enterprise Ireland and NLC
- Latest Funding Round: Grant (prize money), Oct 03, 2025, $*****
NLC's Year-on-Year Investment Trends
NLC has invested in 49 companies over the last 5 years, with an average of 2 new investments annually in the last 5 years. In 2025, it made 2 investments. Its most recent first time investment was in Ansana and most recent follow-on round was in MindAffect.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 0 | 0 | 0 |
2025 | 2 | 0 | 2 |
2024 | 3 | 1 | 4 |
2023 | 0 | 0 | 0 |
2022 | 2 | 0 | 2 |
2021 | 1 | 0 | 1 |
NLC's Investments by Stage
NLC has made 4 investments in Seed stage with an average round size of $1.68M and 4 investments in Series A stage with an average round size of $4.54M.Stage of entry | No. of Investments |
|---|---|
Seed | 4 |
Series A | 4 |
Note: We have considered here, only first round of investments
NLC's Investments by Sector
NLC has a diverse portfolio, with companies operating in the Life Sciences, Healthcare, HealthTech, High Tech and Internet of Things - Industry Applications. Notably, it has invested in 31 Enterprise (B2B) companies, 29 Tech companies, 16 Tech hardware companies and at least 8 companies focusing on Software.Sector | No. of Investments |
|---|---|
Life Sciences | 5 |
Healthcare | 3 |
HealthTech | 1 |
High Tech | 1 |
Internet of Things - Industry Applications | 1 |
Note: We have considered here, only first round of investments
NLC's Investments by Geography
NLC has made most investments in Netherlands (7), followed by United Kingdom where it has made 1 investment.Country | No. of Investments |
|---|---|
Netherlands | 7 |
United Kingdom | 1 |
Note: We have considered here, only first round of investments
NLC's recent investments
NLC has not made any investment in 2026 so far.Here are the most recent investments by NLC:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Sep 25, 2025 | Netherlands | Seed | 2815 | [+1] | |
Jul 07, 2025 | United Kingdom | Seed | 4796 | ||
Oct 14, 2024 | Netherlands | Series A | 3215 | [+2] | |
Jun 03, 2024 | Netherlands | Seed | 5862 | - | |
Apr 29, 2024 | Netherlands | Series A | 1407 |
Team profile of NLC
NLC has a team of 54 members including 11 Partners, 11 Venture Partners and 11 Principals located in Netherlands, United Kingdom and 5 more locations. NLC's team does not sit on the board of any company as of now.Here is a list of top team members in NLC:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | - | - | - | |
Partner | London | - | - | |
Partner | Utrecht | - | ||
Partner | Amsterdam | - | ||
Partner | Boca Raton | - | ||
Partner | Lausanne | - | - | |
Partner | Amsterdam | - | - | |
Partner | Netherlands | - | - | |
Partner | Islamabad | - | - | |
Partner | Bussum | - | - | |
Partner | Las Vegas | - | - |
Co-investors of NLC
Over the past 5 years, 18 investors have co-invested in NLC's portfolio companies. This includes only funds.
- Invested before NLC: EIT Health, Oost NL and 2 others have invested in rounds before NLC. There are 2 companies where EIT Health has invested before NLC and 1 company where Oost NL has invested before NLC.
- Top Co-investors of NLC: 13 investors entered a company along with NLC. These include investors like Demcon (2 companies).
- Invested after NLC: Barco Limpo (1 company) is the only investor which has invested in NLC's portfolio after their investments.
Recent News related to NLC
•
Ansana Secures €1.5M to Enhance Hospital Safety with Sterilization TechnologySilicon Canals•Sep 29, 2025•NLC, BGO, Tanner Health System, Angsana
•
Amsterdam-based NLC Health Ventures expands to 76 active ventures, secures record €43.6M funding and moreSilicon Canals•Feb 21, 2025•NLC
•
NLC Health Venture and Minnesota MedTech 3.0 partner to connect European medtech startups to MinnesotaGlobeNewswire•Feb 20, 2025•NLC, Mnmedtech
•
Rotterdam’s healthtech startup Kaminari Medical bags €3.8M from Graduate Entrepreneur, NLC Health Ventures, othersSilicon Canals•Oct 14, 2024•Kaminari Medical, NLC, Libertatis Ergo Holding, Demcon and 1 other
•
NLC Health Ventures launches new early-stage drug delivery companyBioSpace•Jul 01, 2024•NLC, Verily, Nextbiotix
•
Amsterdam’s NLC Health Ventures and Alphabet’s healthtech company Verily launch new biotech startupSilicon Canals•Jun 24, 2024•NLC, Verily
•
Amsterdam’s SERDA Therapeutics raises €2M to help treat burn injuries and chronic ulcersSilicon Canals•Jun 03, 2024•SERDA Therapeutics, NLC
•
Altach Biomedical raises €1.2m for cartilage injury treatmentSilicon Republic•May 22, 2024•Altach, NLC
•
Dutch healthtech startup MindAffect secures €1.1M funding to simplify hearing diagnostics through AISilicon Canals•Apr 29, 2024•MindAffect, NLC
•
Amsterdam’s NLC Health Ventures raises €14M to back healthcare innovationsSilicon Canals•Mar 04, 2024•NLC
